Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zahir Amoura

Showing results (1-10 of 503) with videos related to

Pageof 51
Sort By:
La Revue Du Praticien|January 23, 2026
[Living with… systemic lupus]Zahir Amoura
Annals of the Rheumatic Diseases|September 8, 2020
Response to: 'Implications of SARS-CoV-2 infection for patients with rheumatic disease' by Lin <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|July 17, 2020
Response to: 'Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India' by Goyal <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|May 27, 2020
Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|September 5, 2020
Response to 'Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic' by Chuah <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|May 31, 2020
Response to: 'Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|July 4, 2020
Response to: 'Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey' by Plüß <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|June 2, 2020
Response to: 'Patients with lupus with COVID-19: University of Michigan experience' by Wallace <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|August 2, 2020
Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|June 10, 2020
Response to: 'Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak' by Holubar <i>et al</i>Alexis Mathian, Zahir Amoura
Pageof 51

Showing results (1-10 of 503) with videos related to

Sort By:
Pageof 51
La Revue Du Praticien|January 23, 2026
[Living with… systemic lupus]Zahir Amoura
Annals of the Rheumatic Diseases|September 8, 2020
Response to: 'Implications of SARS-CoV-2 infection for patients with rheumatic disease' by Lin <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|July 17, 2020
Response to: 'Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India' by Goyal <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|May 27, 2020
Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|September 5, 2020
Response to 'Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic' by Chuah <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|May 31, 2020
Response to: 'Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|July 4, 2020
Response to: 'Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey' by Plüß <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|June 2, 2020
Response to: 'Patients with lupus with COVID-19: University of Michigan experience' by Wallace <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|August 2, 2020
Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|June 10, 2020
Response to: 'Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak' by Holubar <i>et al</i>Alexis Mathian, Zahir Amoura
Pageof 51